The Karolinska University Hospital is a teaching hospital affiliated with Karolinska Institutet in Stockholm, Sweden, with two major sites in the municipalities of Solna and Huddinge. The hospital network is the second largest in Sweden, after Sahlgrenska University Hospital.

There are 1,340 beds in Karolinska University Hospital.

During the past decade, Karolinska University Hospital conducted 348 clinical trials. In the 10-year time frame, 348 clinical trials started and 70 clinical trials were completed, i.e. on average, 20.1% percent of trials that started reached the finish line to date. In the past 5 years, 146 clinical trials started and 38 clinical trials were completed. i.e. 26% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Karolinska University Hospital" #1 sponsor was "Karolinska Institutet" with 123 trials, followed by "Karolinska University Hospital" with 108 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 12 trials sponsored, "Celgene" with 11 trials sponsored and "Uppsala University" with 11 trials sponsored. Other sponsors include 389 different institutions and companies that sponsored additional 257 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Karolinska University Hospital" #1 collaborator was "Karolinska University Hospital" with 68 trials as a collaborator, "Karolinska Institutet" with 38 trials as a collaborator, "Sahlgrenska University Hospital, Sweden" with 28 trials as a collaborator, "The Swedish Research Council" with 24 trials as a collaborator and "University Hospital, Linkoeping" with 22 trials as a collaborator. Other collaborators include 856 different institutions and companies that were collaborators in the rest 545 trials.

According to Clinical.Site data, the most researched conditions in "Karolinska University Hospital" are "Breast Cancer" (15 trials), "Colorectal Cancer" (15 trials), "Multiple Myeloma" (11 trials), "Heart Failure" (8 trials) and "Lymphoma" (8 trials). Many other conditions were trialed in "Karolinska University Hospital" in a lesser frequency.

Most popular intervention types in "Karolinska University Hospital" are "Drug" (294 trials), "Procedure" (105 trials), "Device" (98 trials), "Other" (95 trials) and "Biological" (56 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (47 trials), "Rituximab" (7 trials), "conventional surgery" (7 trials), "Bevacizumab" (6 trials) and "Cyclophosphamide" (6 trials). Other intervention names were less common.

The vast majority of trials in "Karolinska University Hospital" are 576 trials for "All" genders, 59 trials for "Female" genders and 22 trials for "Male" genders.

Currently, there are 233 active trials in "Karolinska University Hospital". 8 are not yet recruiting, 149 are recruiting, 66 are Active, not recruiting, and 10 are Enrolling by invitation. In total, there were 324 completed trials in Karolinska University Hospital, 1 suspended trials, and 43 terminated clinical trials to date.

Out of the total trials that were conducted in Karolinska University Hospital, 55 "Phase 1" clinical trials were conducted, 133 "Phase 2" clinical trials and 156 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 21 trials, and there were also 206 trials that are defined as “Not Applicable".